comprehensive -WSS

comprehensive

author：fashion 2025-10-01 15:28:39 - browse：59

Is no one safe from the FTC? Has Pfizer bottomed out? And is biotech finally back?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, we delve into the fallout over the FTC’s move to block what looked like a humdrum biotech deal between Sanofi and Maze Therapeutics, a surprising twist that leaves an unanswered question. We also discuss the latest news in the life sciences, including Pfizer’s downbeat future, Vertex Pharmaceuticals’ next big thing, and a newly minted biotech VC with a very famous name.

For more on what we cover, here’s the FTC news; here’s more from Maze Therapeutics; here’s the Pfizer news; here’s the latest on Vertex; here’s the story behind its pain drug; here’s the Reed Jobs profile; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Medical records are filled with copy
Next article： UnitedHealth, Optum discontinue NaviHealth name

explore

Wikipedia

WSS

How AI can help patients find reliable information about doctors

Menendez indictment could see pharma lose a key ally

STAT Summit: The economic case for universal basic health care

Intercept Pharmaceuticals sells itself for less than $1 billion

After a drawn out lobbying fight, ARPA

FDA seeks to regulate lab

hotspot

comprehensive

Wikipedia

Medical leaders decry Supreme Court decision on affirmative action

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

The cancer drug shortage isn’t new — and neither are the solutions

Paxlovid should be available without a positive Covid test

In age of alternative facts, a scholarly course on calling out crap

Intercept Pharmaceuticals sells itself for less than $1 billion

The high cost of giving birth even with insurance

Biogen shutters digital health group, ends Apple study, in cost cutting move

Affirmative action in medical school literally saved lives

The problems with dementia villages

Wikipedia

Cassava Sciences’ Alzheimer’s clinical trials should be halted

Medicare drug price negotiation program allowed for now

Would Medicare drug price negotiations stall in a shutdown?

Merck, Daiichi strike cancer drug pact worth up to $22 billion

Why do women spend more than men on medical expenses?

STAT Summit: Meghan O’Rourke on making chronic illness visible

explore

knowledge

Wikipedia

entertainment